Polar Asset Management Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Polar Asset Management Partners’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-83,400	Closed	-$8.5M	–	1036
2023 Q2	$8.5M	Buy	+83,400	New	+$7.89M	0.15%	172

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Polar Asset Management Partners's RETA Position: Q3 2023 in Review

Polar Asset Management Partners sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 83,400 shares — an estimated $8.5M sold.

Polar Asset Management Partners first reported a position in RETA in Q2 2023 and held it in 1 quarter. The position peaked at $8.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Polar Asset Management Partners reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Polar Asset Management Partners sold 83,400 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $8.5M.
Polar Asset Management Partners first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Polar Asset Management Partners's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $8.5M in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Polar Asset Management Partners's 13F filing for Q3 2023, filed 14 Nov 2023.